-
ALSO READ
Board of Biocon approves appointment of Executive Chairperson and MD
Biocon moves up to rank 6th on Science careers' top 20 global pharma list
Biocon elevates Siddharth Mittal to CEO, Joint MD's position
Syngene International drops after muted Q3 earnings
Kiran Mazumdar Shaw conferred with lifetime achievement award by ICMR
-
: Biocon Ltd announced on Monday
that The Medicine Maker Power List 2020 has ranked its Executive Chairperson Kiran Mazumdar-Shaw as one of the world's top 20 inspirational leaders in the field of biopharmaceuticals.
She has been recognised for her contribution to the world of medicine as an entrepreneur and innovative business leader, the Bengaluru-headquartered biopharmaceuticals company said in a statement.
The Medicine Maker Power List 20 for 2020 celebrates 60 great minds who have brought the world innovation in small molecules, biopharmaceuticals and advanced medicine, it said.
It highlights professionals who are driving the industry forward and saving lives by developing new medicines and lending a helping hand in bringing COVID-19 vaccines and treatments to market as soon as possible, according to the statement.
Mazumdar-Shaw has been featuring on the List for six consecutive years since 2015.
Mazumdar-Shaw said it is indeed an honour to be featured on the List alongside G V Prasad and other remarkable and inspirational individuals whose work has positively influenced the fields of small molecules, biopharmaceuticals and advanced medicine.
"At a time when humanity is threatened by a deadly viral pandemic, the world is looking at the medical sciences to get us through the crisis.
The medical science community has risen to the challenge, sharing knowledge of potential treatments, coordinating clinical trials, developing new models of cooperation, and publishing findings immediately to tackle the COVID-19 pandemic," she said.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU